Established markers in second trimester maternal serum
- 30 December 1996
- journal article
- review article
- Published by Elsevier in Early Human Development
- Vol. 47, S27-S29
- https://doi.org/10.1016/s0378-3782(96)01814-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Improved parameters for risk estimation in Down's syndrome screeningPrenatal Diagnosis, 1995
- Impact of a Regional Screening Programme Using Maternal Serum a Fetoprotein (AFP) and Human Chorionic Gonadotrophin (hCG) on the Birth Incidence of Down's Syndrome in the West of ScotlandJournal of Medical Screening, 1994
- Implementation of an Antenatal Serum Screening Programme for Down's Syndrome in Two Districts (Brighton and Eastbourne)Journal of Medical Screening, 1994
- Evaluation of multiple-marker screening for Down syndrome in a statewide populationAmerican Journal of Obstetrics and Gynecology, 1993
- Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin.BMJ, 1993
- A prospective trial of prenatal screening for Down syndrome by means of maternal serum α-fetoprotein, human chorionic gonadotropin, and unconjugated estriolAmerican Journal of Obstetrics and Gynecology, 1993
- Serum screening for Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1993
- Screening for fetal Down syndrome with maternal serum hCG and oestriol: A prospective studyPrenatal Diagnosis, 1992
- Prenatal Screening for Down's Syndrome with Use of Maternal Serum MarkersNew England Journal of Medicine, 1992
- Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.BMJ, 1992